Finally, we identified a subgroup of genetic variants with a concomitant effect on insulin sensitivity and alterations in liver metabolism and inflammation, which could correspond to hepatic insulin-resistance processes, which we called the “hepatic-insulin resistance cluster”. The gene discussed is INS; the disease is Insulin resistance.